You have 9 free searches left this month | to do more
Showing 1 - 25 of
2,082 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma - 2019
Completed
Has Results
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +5 more
  • gemcitabine hydrochloride
  • bendamustine hydrochloride
  • Atlanta, Georgia
  • +1 more
2021-10-21
Oct 21, 2021
S
A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-cell Non-Hodgkin's Lymphoma - 2007
Completed
  • Non-Hodgkin's Lymphoma
  • bendamustine hydrochloride
  • Kanagawa, Japan
  • +3 more
2020-10-19
Oct 19, 2020
J
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
Recruiting
  • Recurrent Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Bendamustine Hydrochloride
  • Brentuximab Vedotin
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
2021-12-17
Dec 17, 2021
U
Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
Recruiting
  • Classical Hodgkin Lymphoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-12-31
Dec 31, 2021
T
Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis
Not yet recruiting
  • Amyloidosis
  • Light Chain (AL) Amyloidosis
  • (no location specified)
2022-03-09
Mar 9, 2022
W
CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
Active, not recruiting
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +16 more
  • 6,8-bis(benzylthio)octanoic acid
  • bendamustine hydrochloride
  • Winston-Salem, North Carolina
  • +1 more
2021-10-28
Oct 28, 2021
W
CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma
Recruiting
  • Relapsed T-Cell Lymphoma
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
2021-08-27
Aug 27, 2021
W
Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma
Active, not recruiting
  • Mantle Cell Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-05-21
May 21, 2021
Y
A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)
Not yet recruiting
  • PTLD
  • +8 more
  • New Haven, Connecticut
  • +1 more
2021-10-28
Oct 28, 2021
C
A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection - 2016
Completed
  • Indolent B-Cell Non-Hodgkin's Lymphomas
  • Bendamustine hydrochloride injection
  • Fuzhou, Fujian, China
  • +10 more
2020-09-25
Sep 25, 2020
E
Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • +3 more
  • Atlanta, Georgia
  • +1 more
2021-08-25
Aug 25, 2021
U
Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - 2021
Completed
  • Lymphoma, Non-Hodgkin
  • Lymphoma
  • Davis, California
  • +2 more
2021-04-21
Apr 21, 2021
C
Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL
Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Polatuzumab vedotin
  • +2 more
  • Brno, Czechia
  • +6 more
2021-05-28
May 28, 2021
K
Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
Active, not recruiting
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +9 more
  • BTK inhibitor PCI-32765
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
2021-02-20
Feb 20, 2021
S
SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors - 2020
Completed
  • Advanced Solid Tumor
  • SyB C-0501
  • Chuo-ku, Tokyo, Japan
  • +1 more
2021-04-25
Apr 25, 2021
M
Carfilzomib, Bendamustine Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - 2021
Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Bendamustine Hydrochloride
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-01-07
Jan 7, 2021
S
Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies
Recruiting
  • Myeloid Leukemia, Acute
  • +3 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
2022-04-04
Apr 4, 2022
T
Bendamustine in the Treatment of Chinese Patients With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment - 2017
Completed
  • Non-Hodgkin Lymphoma
  • Bendamustine hydrochloride
  • Beijing City, China
  • +26 more
2021-11-05
Nov 5, 2021
P
Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age
Recruiting
  • Mantle Cell Lymphoma
  • Urbana, Illinois
  • +10 more
2021-12-21
Dec 21, 2021
S
Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)
Recruiting
  • Leukemia, Acute Lymphoblastic
  • +5 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
2021-06-21
Jun 21, 2021
M
Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma - 2016
Terminated
Has Results
  • Follicular Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-04-01
Apr 1, 2020
S
A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin's Lymphoma - 2020
Completed
  • Hodgkin's Lymphoma
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
2020-05-27
May 27, 2020
S
Safety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab (BeGeRN) in Patients With r/r DLBCL - 2020
Completed
  • Diffuse Large B Cell Lymphoma
  • Bendamustine hydrochloride
  • +5 more
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
2021-06-02
Jun 2, 2021
M
Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma - 2015
Completed
Has Results
  • Refractory Multiple Myeloma
  • bendamustine hydrochloride
  • +2 more
  • Duarte, California
  • +4 more
2020-02-10
Feb 10, 2020
S
A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma - 2010
Completed
  • Non-Hodgkin's Lymphoma
  • +3 more
  • Nagoya-city, Aichi, Japan
  • +3 more
2021-07-01
Jul 1, 2021